Vanda Pharmaceuticals
VNDA
VNDA
117 hedge funds and large institutions have $396M invested in Vanda Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
18% less capital invested
Capital invested by funds: $481M → $396M (-$85.1M)
Holders
117
Holding in Top 10
5
Calls
$4.24M
Puts
$2.26M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$8.1M | |
| 3 | +$3.92M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.59M |
| 5 |
Renaissance Technologies
New York
|
+$3.14M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$9.39M | |
| 3 | -$8.46M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$8.04M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.44M |